Hematologic Malignancies

Filter By:
01:55
Patients with cancer undergoing chemotherapy and radiation may be at risk for Oral Mucositis, a condition characterized by redness, inflammation and ulcer like sores throughout the mouth and throat. Oral Mucositis can be extremely painful and may also lead to infection. The following tips can be hel...
by:DARABioSciences | 1554 views
06:52
Louis M. Weiner, MD, explains that checkpoint inhibitors represent a promising treatment option for essentially all types of cancer, since a tumor cannot form without first overcoming the immune system. To view more from this discussion, visit http://www.o...
by:onclivetv | 555 views
05:20
Jean DiCarlo-Wagner is a vibrant Stage III Colorectal Cancer Survivor turned yoga instructor. In this video, she shares her gift of teaching Yoga to cancer survivors at National Women's Survivor Convention. Jean invites you to take your shoes off, enjoy some monkey-see, monkey-do yoga and relax. Sh...
by:SayYEStoHOPE | 1210 views
17:46
Download from iTunes: https://itun.... Acute Myeloid leukemia (AML) involves an overgrowth of immature blood cells, while myelodysplastic syndromes (MDS) happen when the bone marrow does not produce enough blood cells. MD Anderson Cancer Center is the world's largest p...
by:mdanderson | 1140 views
19:19
This series of interviews with eight expert faculty is filmed on location during the 2014 American Society of Clinical Oncology (ASCO) Annual meeting, where the most current cancer data is presented and examined. Following the scientific sessions, Dr. James Epstein reviews and explores some of the most significant research findings in multiple tumo...
by:imedex | 331 views
18:36
Patients with multiple myeloma that is refractory to both bortezomib and lenalidomide have an especially poor prognosis. This double-refracto​ry indication is emerging as a significant clinical challenge as these two agents are now commonly used as frontline and maintenance therapies. However, recent...
by:imedex | 277 views
10:37
Patients with multiple myeloma that is refractory to both bortezomib and lenalidomide have an especially poor prognosis. This double-refracto​ry indication is emerging as a significant clinical challenge as these two agents are now commonly used as frontline and maintenance therapies. However, recent...
by:imedex | 1074 views
13:32
Patients with multiple myeloma that is refractory to both bortezomib and lenalidomide have an especially poor prognosis. This double-refracto​ry indication is emerging as a significant clinical challenge as these two agents are now commonly used as frontline and maintenance therapies. However, recent...
by:imedex | 267 views
18:36
Recent advances in basic and clinical research have enhanced our understanding of the underlying biological and genetic variations associated with myeloproliferat​ive neoplasms. These advances have enhanced classification and diagnosis of disease, contributed to more robust risk stratification models and identified novel targeted therapies for the o...
by:imedex | 287 views
20:50
Recent advances in basic and clinical research have enhanced our understanding of the underlying biological and genetic variations associated with myeloproliferat​ive neoplasms. These advances have enhanced classification and diagnosis of disease, contributed to more robust risk stratification models...
by:imedex | 268 views

Top Tags



Please help us provide the best service.
I'm intersted in oncology videos because I'm a...

Oncologist 
Different type of MD 
Nurse 
Other oncology Professional 
Patient/Advocate 
Something Else 

No Thanks(close window)
Membership has its privileges.
 I want the OncologyTube newsletter 

 I want to share videos & receive the newsletter 

I already have an account log me in.


username:   password: remember me

Sign In

Username:
Password:
Remember me
Forgot your password?
Not Yet a Member? Sign up for FREE here!
(Skip Ad)